Thomas Schwaab, MD, PhD

Thomas Schwaab, MD, PhD

Chief of Strategy, Business Development and Outreach
Associate Professor of Oncology
Department of Urology
Department of Immunology
CEO, RPCI Oncology, PC
Roswell Park Cancer Institute
Areas of Expertise: 
Bladder cancer
Kidney cancer
Prostate cancer
Testicular cancer
Partial nephrectomy
Robotic kidney surgery
Retroperitoneal surgery
IVC surgery advanced in kidney cancers
Special Interests: 
Role for partial nephrectomy
Immunotherapy for bladder, prostate and kidney cancers
Robotic simulation


Thomas Schwaab, MD, PhD, is Roswell Park's Chief of Strategy, Business Development and Outreach. Dr. Schwaab is also an Associate Professor of Oncology and Immunology, and joined the Institute’s faculty in 2009. In his new role, Dr. Schwaab supervises RPCI’s business development and overall strategic development. He assures that business and clinical initiatives are delivered appropriately and support maximal quality, efficiency and effectiveness, and works to continually widen the Institute’s scope of operations and growth potential at national and international levels.


Education and Training: 
MD - Medizinische Hochscule Hannover, Hannover, Germany
PhD - Medizinische Hochscule Hannover, Hannover, Germany
Klinikum Lippe-Detmold, Detmold, Germany
Dartmouth-Hitchcock Medical Center, Lebanon, NH
Tumor Immunotherapy Program, Dartmouth College, Hanover, NH
Board Certification: 
Urology, American Board of Urology